Lisa Miller


Using Antibiotics Could Affect Checkpoint Inhibitors

February 14, 2017

A recent study presented at the 2017 Genitourinary Cancers Symposium found that use of antibiotics could damper the efficacy of checkpoint inhibitors, potentially due to the relationship between gut microbiota and antibiotics.

Everolimus/Fulvestrant Combo Improves Survival in HR+ Breast Cancer

December 08, 2016

According to phase II trial findings, adding everolimus to fulvestrant significantly improved progression-free survival for postmenopausal patients with metastatic hormone receptor-positive, HER2-negative breast cancer who are resistant to aromatase inhibitor therapy.